Drug bulletin

 

 

Details of drug bulletin:

“Drugs bulletin” is quarterly journal (ISSN 0970-2229) published by department of Pharmacology, PGIMER, Chandigarh. The first issue was published in 1975. The journal is published in January, April, July and October every year. This journal contains reviews on important topics by reputed authors. The journal went online from 2013 issues onwards.

The bulletin is registered under “International society of Drug Bulletins” and World Health Organization (WHO) has published a case study on “Drug Bulletin”, PGIMER in their article on “Starting or Strengthening a Drug Bulletin - A Practical Manual”.

Target audience of the journal: Doctors working in periphery, medical scientists, pharmacologists, basic medical scientists.

Submission guideline:

  1. ICMJE guideline to be followed.
  2. Review can be mailed to drugbulletinpgi@gmail.com
  3. Articles will be subjected to a double blind peer review system.
  4. Only high quality articles successfully defending peer review system will be accepted for publication.
  5. Articles above similarity index of >10% will not be published.
  6. Articles will be published both online and in print.

Current Drugs bulletin committee

Chairperson and editor

Prof. A. Chakrabarti

Members

Prof. Samir Malhotra

Prof. Bikash Medhi

Dr. Debashis Hota

Dr. Nusrat Shafiq

Dr. Lekha Saha

Dr. Smita Pattanaik

Advisory committee chairman

Prof. Y. Chawla

Members

Prof. Amod Gupta

Prof. V. Sakhuja

Prof. K. Joshi

Prof. S K Jindal

Editorial assistant

Dr. Phulen Sarma

Journal DesignerMr. Shammy Chandel

 

Now we are completing the backlog of 2015-2017 issues.

Drug bulletin details.

 

Publications

Year

Volume and issue

Articles

2013

January 2013

Sarma P, Radhika A, Chakrabarti A, Medhi B. Newer Antiepileptic Drugs. 2013 38(2): 1-45

April 2013

Shyambalaji A, Sarma P, Medhi B, Chakrabarti A. Lifestyle drugs. 2013 38(2): 1-21

July 2013

Krishnamurthy B, Medhi B. Gestational Diabetes Mellitus. 2013 38(3): 1-29

October 2013

Bhagat R, Kumar H, Sarma P, Singh S, Chakrabarti A, Medhi B. Orphan Drug and Disease. 2013 38(4): 1-27

2014

January 2014

Singh S, Chandel S, Bhagat R, Medhi B. Quality of Medicine. Drug bulletin 2014:39 (1): 1-5

 

April 2014

Radhika A, Sarma P, Medhi B. Personalized therapy: Current prospects and practical implications. Drug bulletin 2014: 39 (2): 1-9

 

July 2014

Bhagat R, Kumar H, Sarma P, Mishra A, Medhi B. Drug eluting stents. Drug Bulletin 2014: 39 (3): 1-9

 

October 2014

Reddy DH, Soni H, Chandel S, Medhi B. Post stroke dementia and treatment. Drug Bulletin 2014: 39 (4): 1-8

2015January 2015
Soni S, Sarma P, Medhi B. Materivigilance: Indian perspective. Drug bulletin 2015: 40
(1): 1-15

Soni S, Sarma P, Medhi B. Materivigilance: Indian perspective. Drug bulletin 2015: 40 (1): 1-15

 April 2015

Rohila R, Kumar P, Naveen M, Medhi B. Novel ocular drug delivery methods. Drug Bulletin 2015. 40(2): 1-10

 July 2015Krishnamurthy B, Medhi B. MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT. Drug Bulletin 2015; 40(3): 1]17. 
 October 2018

Mothsara C, Patil A. Alternative therapy, Safety and efficacy: A Critical analysis with respect to Indian scenario. Drug Bulletin 2015; 40(4): 1-8

2016January 2016

Sahoo S, Padhy SK, Avasthi A, Singh A, Sarma P. An update on the newer antipsychotics: last decade. Drug Bulletin 2016; 41(1): 1-12